Mobile Site ›

The Classic Myeloproliferative Neoplasms

Optimizing Laboratory Testing for Hematologic Disorders Series

Conclusion #1 — JAK2 V617F

Slide 15

October 2011

So our first conclusion is that blood and marrow studies for the JAK2 V617F mutation will give similar diagnostic results. Thus, only 1 specimen, either peripheral blood or bone marrow, needs to be analyzed, but certainly not both. And finally, in data that I didn’t show, the mutation levels of the JAK2 V617F also appear to be comparable between blood and bone marrow.

Conclusion #1 — JAK2 V617F


Jump to section: